Quick Answer
Monte Rosa Therapeutics, Inc. reported Shares Outstanding of 65.54 million shares for fiscal year 2025.
Monte Rosa Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 65.54M | +6.6% |
| 2024 | 61.51M | +22.7% |
| 2023 | 50.14M | +1.7% |
| 2022 | 49.32M | +6.0% |
| 2021 | 46.54M | +2660.9% |
| 2020 | 1.69M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 61.79M | +0.7% | +0.1% |
| June 30, 2025 | 61.72M | +0.6% | +0.3% |
| March 31, 2025 | 61.51M | +22.5% | +0.0% |
| December 31, 2024 | 61.51M | +22.7% | +0.2% |
| September 30, 2024 | 61.38M | +22.6% | +0.1% |
| June 30, 2024 | 61.33M | +23.7% | +22.2% |
| March 31, 2024 | 50.20M | +1.7% | +0.1% |
| December 31, 2023 | 50.14M | +1.7% | +0.1% |
- Monte Rosa Therapeutics, Inc. showed an increase of +6.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Monte Rosa Therapeutics, Inc.’s shares outstanding has grown by 3788.6% (from 1.69 million shares to 65.54 million shares).
- The most recent figure is from Monte Rosa Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: